About GT+R 2023
Join leading biopharmaceutical and biotechnology executives, patient advocacy groups, and seasoned solution providers in discussing current trends, evolutionary innovations, strategic business models, real-world solutions, and so much more within the gene therapy industry.
Join GT+R 2023 for Three (3) days in Peabody from June 26 - 28, 2023 for a comprehensive program and inclusive gathering of gene therapy experts.
Senior VP, Strategic Partnerships, New York Stem Cell Foundation
Department Chairman, Department of Urology, UT MD Anderson Cancer Center
President and CEO, AlphaNet, Inc.
CEO and Founder, REACH Market Research
Global Vice President, Cell and Gene Therapy Strategy Lead, PPD
Chief Scientific Officer & Co-Founder, AXONIS Therapeutics
Chief Executive Officer, Houston Gene Therapeutics
President & CEO, Cornerstone Pharmaceuticals
Andrew B. Harmon
JONI L. RUTTER
Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH)
GT+R Executive Planning Committee
President and Founder
RAJESH B. SHUKLA
Senior Medical Director
Why Attend GT+R 2023
The time is now for action. Attendees will have the opportunity to:
Engage with vetted thought-leaders and seasoned industry, advocacy, academic and community-based stakeholders
Participate in strategically designed networking sessions and breaks
Identify and explore professional development opportunities
Identify and discuss novel, sustainable solutions to therapeutic development pain points & issues
Learn about innovative collaborations that are on the frontier and foster new ones
Participate at the first of its kind gene therapy and rare disease conference designed by a collaboration of seasoned industry experts
RESERVE YOUR SPOT TODAY
Holiday Inn & Suites
Peabody, MA 01960, United States
A limited number of rooms have been blocked for GT+R attendees at the Holiday Inn & Suites,Peabody. You may confirm your lodging accommodation at the discounted rate of $240.00 USD per night upon purchasing your conference ticket(s).
Due to limited availability, lodging accommodations will be treated on a “first come first serve” basis.
For any inquiries regarding accommodation, please contact: firstname.lastname@example.org
Attendee Snapshot GT+R 2023
Executive decision-makers in the fields of gene therapy and rare diseases are the majority of attendees registered for GT+R 2023. The following is a list of stakeholders in which we expect the largest participation on a global scale:
Patient Advocacy & Community
Recruitment & Retention
Commercial & Media Services
Digital Health Diagnostics
Market Research & Global Access